NCT01151787View on ClinicalTrials.gov

Efficacy and Safety of Cyclobenzaprine Hydrochloride Extended Release for the Treatment of Chronic Migraine

PHASE3TerminatedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

July 31, 2010

Primary Completion Date

September 30, 2013

Study Completion Date

September 30, 2013

Conditions
Chronic Migraine
Interventions
DRUG

cyclobenzaprine hydrochloride

15mg daily for 3 months

DRUG

placebo

placebo

Trial Locations (1)

08002

The Headache Center at Kennedy Health Alliance, Cherry Hill

Sponsors
All Listed Sponsors
collaborator

Teva Pharmaceuticals USA

INDUSTRY

lead

Kennedy Medical Group

OTHER